While the BsAb was designed to enhance T cell immunity, as described above, CDX-527 binds to activating FcγRs and thereby can potentially mediate effector function such as ADCC against certain tumor cells overexpressing PD-L1 or CD27. The gene discussed is CD274; the disease is neoplasm.